CONTACT
Group Companies
VIDEO GALLERY
Biocon Biologics to Acquire Viatris Global Biosimilars Assets for upto USD 3.335 bn in stock & cash
Biocon Biologics: ensuring seamless care, to instill endless hope for cancer care.
World Cancer Day: We are committed to close the cancer care gap
Happy New Year 2022: As we enter the 2022, we renew our commitment to serve patients, enable equitable access & impact global health.
Biocon Biologics: Bringing A Paradigm Shift in Affordable Cancer Care!
Know more
about us
BUSINESSES
FINANCIAL CALENDAR
KEY MANAGEMENT TEAM
OUR LEGACY
